Valneva SE (VALN) Gains from Investment Securities (2021 - 2026)

Valneva SE's (VALN) quarterly Gains from Investment Securities came in at -$1170.7 in Q1 2026, up 99.73% year-on-year from -$586.17 in Q1 2025, and up 99.93% quarter-over-quarter from -$1.7 million in Q3 2025.

Valneva SE (VALN) Gains from Investment Securities (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Gains from Investment Securities across 6 years of filings, most recently posting -$1170.7 for Q1 2026.

  • Gains from Investment Securities for Q1 2026 came in at -$1170.7, up 99.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 20.33% YoY), and the FY2024 annual result was -$1.7 million, down 24.15% from the prior year.
  • Gains from Investment Securities came in at -$1170.7 for Q1 2026 at Valneva SE, up from -$1.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $699.0 million in Q3 2023 to a low of -$699.7 million in Q2 2023.
  • The 5-year median for Gains from Investment Securities is -$352216.0 (2022), against an average of -$362552.2.
  • Peak annual rise in Gains from Investment Securities reached 262688.54% in 2023, while the deepest fall reached 131047.09% in 2023.
  • Valneva SE's Gains from Investment Securities stood at $946789.6 in 2022, then slumped by 136.71% to -$347528.6 in 2023, then soared by 104.0% to $13891.7 in 2024, then tumbled by 12681.13% to -$1.7 million in 2025, then soared by 99.93% to -$1170.7 in 2026.
  • The last three Gains from Investment Securities figures came in at -$1170.7 (Q1 2026), -$1.7 million (Q3 2025), and -$185641.4 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,170.75
Mar 31, 2026 -1,170.75
Sep 30, 2025 -1.75 Mn
Sep 30, 2025 -1.75 Mn
Jun 30, 2025 -185,641.39
Jun 30, 2025 -185,641.39
Mar 31, 2025 -432,324.50
Mar 31, 2025 -432,324.50
Dec 31, 2024 13,891.74
Dec 31, 2024 13,891.74
Sep 30, 2024 -496,395.22
Sep 30, 2024 -496,395.22
Jun 30, 2024 -1.05 Mn
Jun 30, 2024 -1.05 Mn
Mar 31, 2024 -140,140.67
Mar 31, 2024 -140,140.67
Dec 31, 2023 -347,528.59
Dec 31, 2023 -347,528.59
Sep 30, 2023 698.97 Mn
Sep 30, 2023 698.97 Mn